Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion type Assertion NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_head.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion description "[PC-9 cells and A549 cells, the lung adenocarcinoma cells with mutant and wide-type EGFR respectively, were treated with docetaxel/gefitinib alone or in different combination schedules.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_provenance.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion evidence source_evidence_literature NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_provenance.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion SIO_000772 25474307 NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_provenance.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion wasDerivedFrom befree-2016 NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_provenance.
- NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_assertion wasGeneratedBy ECO_0000203 NP1244794.RA6986uIssUw4OGD8z6l08R5a7SMuWJulVn-6tXMzlbFU130_provenance.